Document:

POWI-EX10.2_2022.6.30_Q2

​

 
Exhibit 10.2
POWER INTEGRATIONS, INC.
​
LETTER AGREEMENT RE: EXECUTIVE OFFICER BENEFITS AGREEMENT
​
This Letter Agreement Re: Executive Officer Benefits Agreement (the “Letter Agreement”) is made and entered into as of August 1, 2022 (the “Effective Date”), by and between Power Integrations, Inc., a Delaware corporation, (the “Company”) and Yang Chiah Yee (“Executive”).
Whereas, Executive is an executive officer of the Company and possesses valuable knowledge of the Company, its business and operations, and the markets in which the Company competes, and the Company desires to supplement Executive’s employment arrangements so as to provide additional benefits to the Executive to encourage Executive to continue to devote his attention and dedication to the Company and its business.
Whereas, the Company and Executive previously entered into an Executive Officer Benefits Agreement by and between the Company and Executive, dated June 14, 2021 (the “EOBA”).
Now, Therefore, in consideration of the mutual agreements, covenants and considerations contained herein, the undersigned hereby agree and acknowledge that, notwithstanding the definition of “Senior Executive” set forth in the EOBA, for the purposes of the EOBA Executive is hereby deemed a “Senior Executive” thereunder as of the Effective Date.
In Witness Whereof, the undersigned have executed this Letter Agreement, intending to be legally bound as of the Effective Date.
	COMPANY:
​
	Power Integrations, Inc.
By:    /s/ BALU BALAKRISHNAN
       Name: Balu Balakrishnan
Title:   President and CEO
​

	​
	​

	EXECUTIVE:
​
​
​
	​
​
  /s/ YANG CHIAH YEE 
Yang Chiah Yee 
​

​

​POWI-EX10.3_2022.6.30_Q2

Exhibit 10.3
[*] = Certain identified information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) is the type of information that Power Integrations, Inc. treats as private or confidential.
​

AMENDMENT NUMBER EIGHT TO THE AMENDED AND RESTATED 
WAFER SUPPLY AGREEMENT
This Amendment Number Eight (the “Amendment”) effective as of July 26, 2017 (the “Amendment Effective Date”)  amends the Amended and Restated Wafer Supply Agreement effective as of April 1, 2003 as further amended by Amendment Number One, effective August 11, 2004, Amendment Number Two, effective April 1, 2008, Amendment Number Three, effective June 9, 2008, Amendment Number Four, effective as of June 13, 2008, Amendment Number Five, effective as of November 14, 2008, Amendment Number Six, effective as of November 1, 2015 and Amendment Number Seven effective as of August 8, 2016, (the "Agreement"), by and between Lapis Semiconductor Co., Ltd., a Japanese corporation having its registered head office at 2-4-8 Shinyokohama, Kohoku-ku Yokohama 222-8575 Japan (“Lapis”), and Power Integrations International, Ltd. ("PI") a Cayman Islands corporation having its principal place of business at 4th Floor, Century Yard, Cricket Square, Elgin Avenue, P.O. Box 32322, Grand Cayman K Y 1-1209. Unless specifically designated otherwise, capitalized terms used herein shall have the same meanings given them in the Agreement.
RECITALS
WHEREAS, PI and LAPIS desire to amend the terms of the Agreement; and
WHEREAS, in accordance with Section 18. 10 of the Agreement, the Agreement may be amended only by an instrument in writing duly executed by authorized officers of LAPIS and PI.
Now, THEREFORE, in consideration of the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby amend the Agreement as follows:
AGREEMENT
The following sections shall be amended as follows: 
		1.	Section 13.1 is deleted in its entirety and replaced with the following:

13.1 This Agreement shall continue in full force and effect from the Effective Date until April 1, 2028, unless earlier terminated as provided herein (“Term”).
2.The following words shall be newly added after the last sentence of Section 13.5.
“Notwithstanding foregoing that, in the event that PI shall be acquired or controlled, directly or indirectly, by, or shall be consolidated or merged into, any other company or corporation, PI shall notify LAPIS thereof in advance, and shall be obligated to have PI’s successor assume the obligations of the Agreement.

​

​

The following shall be added as a new Article or sections as follows:
		3.	Addition of section 18.17 

18.17[ * ] Provider
SUPPLIER shall have the right to have WAFERS manufactured, in whole or in part, by [ * ], provided PI gives its written approval therefor in advance, which approval shall be at PI’s sole discretion.  If PI does give such written approval, then SUPPLIER may disclose PI CONFIDENTIAL  MANUFACTURING INFORMATION for the sole purpose of, and only to the extent reasonably necessary for, having such [ * ] provide such services solely for the benefit of PI and not for the benefit of any other party.  Such approval shall be conditioned upon:
(a)PI’s prior review and written approval of the contract between SUPPLIER and such [ * ] performing such manufacture; and
(b)The [ * ] agreeing in writing to all applicable terms and conditions of this Agreement, and;
(c)SUPPLIER being the insurer and guarantor of such [ * ] full observance of such terms and conditions; and
(d)SUPPLIER’s disclosure of CONFIDENTIAL MANUFACTURING INFORMATION to such [ * ] being subject to PI’s prior written approval, which shall be at PI’s sole discretion.
		4.	Article 24[ * ] Wafer Manufacturing. 

24.1[ * ]MANUFACTURING COMPANY [ * ] which is engaged in providing wafer foundry services for LAPIS subject to such service contract with LAPIS.
24.2.Foundry Commitment for Capacity
SUPPLIER agrees to commit to PI that the foundry capacity is [ * ] (or equivalent for future processes) WAFERS per month [ * ] (or equivalent) WAFERS per month if needed) manufactured in [ * ] (“[ * ] FOUNDRY CAPACITY”). PI shall provide SUPPLIER with [ * ] month prior written notice requesting the [ * ] FOUNDRY CAPACITY to be increased to [ * ] (or equivalent) WAFERS. Upon such request the parties will negotiate the investment for expanding the [ * ] FOUNDRY CAPACITY to [ * ] (or equivalent) WAFERS [ * ].
24.3.Term and Termination of [ * ] FOUNDRY
24.3.1[ * ] shall provide the [ * ] FOUNDRY CAPACITY for [ * ] from the qualification of the [ * ] process, unless earlier terminated as provided herein.  
24.3.2LAPIS shall have the right to terminate this Amendment after that the total quantity of the WAFERS purchased and received by PI amounts to [ * ] WAFERS manufactured by [ * ] and by subsequently providing PI with [ * ] written notice.

​

​

24.4Price and Investment
24.4.1Price for [ * ] WAFERS
The price for the additional [ * ] (or equivalent) WAFERS per month manufactured in [ * ] will be priced the same as the price of the same product manufactured in LAPIS-[ * ] and subject to the same [ * ] exchange formula and other terms as currently in force between PI and LAPIS under the Agreement.  A price negotiation will be made by the management of PI and LAPIS after [ * ] WAFERS have been purchased and received by PI or the expiry of [ * ] after qualification of the [ * ] process whichever comes first. 
24.4.2Investment by PI
In order to secure the additional capacity of [ * ] (or equivalent) WAFERS per month from [ * ] at the same price as the same product WAFER price in the LAPIS-[ * ], PI will make an investment of [ * ] dollars, representing an additional [ * ] (or equivalent) WAFER until [ * ] WAFERS manufactured by [ * ] have been purchased by PI.  Payment terms for the [ * ] are net thirty (30) days from the date of receipt of a proper invoice.
24.5.[ * ] charges
24.5.1[ * ] dollars (USD) will be paid by PI to LAPIS within 30 days of the Amendment Effective Date as an advance for [ * ] charges and will be nonrefundable if PI decides not to proceed with any future developments. 
24.5.2[ * ] charges represent the anticipated level of work as follows (full development plan to follow): 
[ * ] dollars -   for the [ * ] process    [ * ].
[ * ] dollars -   for the [ * ] process  [ * ].
[ * ] dollars -   for the [ * ] process   [ * ]. 
24.6.Production Start
The very first production will commence no later than [ * ].
​
​
[Signatures to follow on the next page]
​

​

​

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed in their respective corporate names by their duly authorized representatives on the date written below.
	_/s/ Akira Yamazaki__________ 
AKIRA YAMAZAKI_______________
GENERAL MANAGER______________
2017 – 8 - 3____________________
​

	/s/ Raja Petrakian__________ 
RAJA PETRAKIAN_______________
Vice President Operations_______
August 4, 2017________________
​

	LAPIS Semiconductor Co., Ltd.
	POWER INTEGRATIONS INTERNATIONAL, Inc.

	Signature:  /s/ Akira Yamazaki 
	Signature:  /s/ Raja Petrakian 

	Name:  AKIRA YAMAZAKI
	Name:  RAJA PETRAKIAN

	Title:  GENERAL MANAGER
	Title:  Vice President Operations

	Date:  2017 – 8 – 3
	Date:  August 4, 2017

​

​Exhibit 10.1

      

    

      
      EXCHANGE AGREEMENT

       

      This Exchange Agreement (this “Agreement”) is made and entered into as of August 3, 2022 by and among Green Plains Inc., an Iowa corporation (the “Company”), and each of the entities (each, a “Noteholder” and, collectively, the “Noteholders”) listed on Schedule “A” attached to this Agreement (collectively, “Schedule A”; the Schedule A pertaining to each individual Noteholder is referred to herein as the “applicable Schedule A”, and the accounts, if any, on behalf of which any Noteholder may be acting, as specified on the applicable Schedule A, for whom the
        Noteholder holds contractual and investment authority, are referred to herein as the “Represented Accounts”). The Company and the Noteholders are sometimes collectively referred to in this
        Agreement as the “Parties” and individually as a “Party”.

       

      WHEREAS, the Noteholders or Represented Accounts currently own $6,500,000 aggregate principal amount of the Company’s 4.125% Convertible Senior
        Notes due 2022 (the “Existing 2022 Notes”); and

       

      WHEREAS, the Parties desire that the Company acquire, and that each Noteholder delivers to the Company, the principal amount of the Existing 2022
        Notes owned by each such Noteholder or its Represented Account and specified in the applicable Schedule A in exchange for the Company’s issuance to such Noteholder or its Represented
        Account of shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), upon the terms and conditions set forth in this Agreement.

       

      NOW, THEREFORE, in consideration of the mutual covenants, agreements and understandings herein contained, the Parties agree as follows:

       

      SECTION 1.       Exchange.

       

      1.1          Exchange of Existing 2022 Notes.

       

      (a)         On and subject to the terms and
            conditions set forth in this Agreement and in reliance upon the representations and warranties set forth below, on the Closing Date (as defined below), the Company shall acquire from each Noteholder or its Represented Account, and each
            Noteholder shall transfer, assign and deliver to the Company, all of its or its Represented Account’s rights, title and interest in the aggregate principal amount of the Existing 2022 Notes owned by such Noteholder and as set forth in the
            applicable Schedule A hereto for such Noteholder, free and clear of any Liens (as defined below), in exchange for (i) a number of shares of Common Stock equal to the Exchanged Shares,
            free and clear of any Liens to be issued at the Closing as contemplated herein, plus (ii) an amount in cash equal to the accrued and unpaid interest on such Existing 2022 Notes to and including the Closing Date as calculated in accordance with
            that certain indenture by and between the Company and the Trustee, dated August 15, 2016 (the “Indenture”), relating to the Existing 2022 Notes (such interest payment, in the amounts
            shown on Schedule A hereto, the “Cash Interest Payment”). The Cash Interest Payment shall be made by wire transfer to the
            account of the Noteholder specified in the applicable Schedule A at the Closing.

       

      (b)         No additional consideration for any
            purpose shall be due to the Noteholders in respect of such Existing 2022 Notes other than the Exchanged Shares issuable hereunder and the Cash Interest Payment.

       

      
        1

        
          

      

      (c)        Within one day following the end of
            the VWAP Period, the Company shall deliver a certificate to each Noteholder setting forth the Company’s determination of the applicable number of Exchanged Shares, and such Noteholder shall promptly thereafter confirm in writing its agreement
            with such calculation. To the extent there is any disagreement in the calculation of the Exchange Ratio or the Exchanged Shares, the Company and the applicable Noteholder shall confer in good faith and confirm the calculation and determination
            of the number of Exchanged Shares. To the extent no agreement is reached between the Company and the applicable Noteholder and judicial proceedings are instituted to resolve such dispute, the non-prevailing party in such dispute shall pay the
            legal costs and expenses of the prevailing party in such dispute.

       

      1.2          Delivery of Exchanged Shares.  Notwithstanding anything herein to the contrary, but subject to Section 1.2(b) and the conditions set forth in Section 1.4, at
            the Closing, the Company shall issue and deliver to each Noteholder the number of Exchanged Shares equal to the number of Exchanged Shares as finally determined pursuant to Section 1.1(c).

       

      1.3          Announcement of the Transactions.  The Company shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date hereof, issue one or more press releases or file with the Securities
            and Exchange Commission (the “Commission”) a Current Report on Form 8-K (collectively, the “Disclosure Document”)
            disclosing, to the extent not previously publicly disclosed, all material terms of the transactions contemplated hereby and any other material, nonpublic information that the Company or any of its respective officers, directors or employees has
            provided to any Noteholder at any time prior to the issuance or filing, as applicable, of the Disclosure Document.

       

      1.4          Closings.

       

      (a)          The closing of the transactions
            contemplated by Section 1.1 with respect to the Exchanged Shares (the “Closing”) will take place on the second business day following final determination of the calculations
            contemplated in Section 1.1(c), subject to this Section 1.4 and to the satisfaction or waiver of the conditions set forth in this Section
                1.4 (other than those that by their terms are to be satisfied or waived at the Closing) or at the first date thereafter as the conditions set forth in this Section 1.4 have been satisfied or waived (the “Closing Date”).

       

      (b)         On the Closing Date, each Noteholder
            shall (i) direct the eligible Depository Trust Company (“DTC”) participant through which such Noteholder, or its Represented Account, holds a beneficial interest in the Existing 2022
            Notes to submit a one-sided withdrawal instruction through DTC’s DWAC program to Wilmington Trust, National Association, as custodian and trustee for the Existing 2022 Notes (the “Trustee”),
            of such Noteholder’s, or its Represented Account’s, Existing 2022 Notes set forth on such Noteholder’s applicable Schedule A, on (and not before) the Closing Date no later than 9:30
            a.m., New York City time, on the Closing Date (and such Noteholder acknowledges that any such withdrawal instruction submitted on any day before the Closing Date will expire unmatched at the close of business on such day and will need to be
            resubmitted on the Closing Date); and (ii) submit, for its own account or the account of its Represented Account, through the DTC’s DWAC program, a deposit instruction to Continental Stock Transfer & Trust Company, acting as transfer agent
            and DTC custodian for the Common Stock (the “Stock Transfer Agent”), for the aggregate number of Exchanged Shares applicable to such Noteholder, which deposit instruction must be
            submitted on (and not before) the Closing Date no later than 9:30 a.m., New York City time, on the Closing Date (and such Noteholder acknowledges that any such deposit instruction submitted on any day before the Closing Date will expire
            unmatched at the close of business on such day and will need to be resubmitted on the Closing Date).

       

      
        2

        
          

      

      (c)         On the Closing Date, the Company shall
            deliver or caused to be delivered to such Noteholder or Represented Account the number of Exchanged Shares set forth on Schedule A applicable to such Noteholder via book-entry
            delivery pursuant to DWAC instructions specified on the applicable Schedule A, with any transfer taxes payable in connection with the delivery of such Exchanged Shares duly paid by
            the Company; provided that it is understood that no delivery of such Exchanged Shares shall be made until a valid DWAC withdrawal instruction for the Existing 2022 Notes and a valid DWAC deposit instruction for such Exchanged Shares has been
            received by the Trustee and the Stock Transfer Agent.

       

      (d)         On the Closing Date, the Company will
            deliver to such Noteholder the applicable Cash Interest Payment by wire transfer to the account of such Noteholders, or its Represented Accounts as set forth on the applicable Schedule A.

       

      (e)         As a condition to the Closing, as of the
            Closing Date, the Exchanged Shares shall have been approved for listing on the Nasdaq Global Select Market (“Nasdaq Market”) without requiring approval thereof by the Company’s
            stockholders under the rules of the Nasdaq Market, subject to official notice of issuance.

       

      (f)          If (i) the Trustee is unable to locate
            the Noteholder’s DWAC withdrawal in respect of the Existing 2022 Notes, (ii) the Stock Transfer Agent is unable to locate the DWAC deposit in respect of the Exchanged Shares or (iii) such DWAC withdrawal or DWAC deposit does not conform with
            the Existing 2022 Notes or the Exchanged Shares to be exchanged or issued, as applicable, pursuant to this Agreement, the Company will promptly notify the applicable Noteholder. If, because of the occurrence of such an event, the Exchanged
            Shares are not delivered on the Closing Date, they will be delivered on the business day following the Closing Date, on which the Trustee is able to locate the DWAC withdrawal or the Stock Transfer Agent is able to locate the DWAC deposit
            and/or the DWAC withdrawal or DWAC deposit conforms with the Existing 2022 Notes or the Exchanged Shares, as applicable. All questions as to the form of all documents and the validity and acceptance of the Existing 2022 Notes and the issuance
            of the Exchanged Shares will be determined by the Company, in its reasonable discretion, which determination shall be final and binding.

       

      SECTION 2.     Representations and Warranties of the Company.  The Company hereby represents and warrants to each Noteholder that:

       

      2.1          Organization.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Iowa.

       

      2.2          Authorization.

       

      (a)          The Company has full right, power and
            authority to execute and deliver this Agreement and to perform its obligations hereunder; and subject to Section 2.6, all action required to be taken for the due and proper
            authorization, execution and delivery by it of this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken.

       

      
        3

        
          

      

      (b)          This Agreement has been duly authorized,
            executed and delivered by the Company and constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
            insolvency, moratorium, reorganization or similar laws affecting creditors’ rights generally and by general equitable principles.

       

      2.3          Validity of the Shares.  The Company has duly authorized and reserved for issuance a number of shares of Common Stock equal to the maximum number of Exchanged Shares that may be issued pursuant to this Agreement. When
            issued and delivered in accordance with the terms of this Agreement, the Exchanged Shares will be validly issued, fully paid and nonassessable, and the issuance of any such Exchanged Shares will not subject to any preemptive or similar rights.

       

      2.4          SEC Filings.

       

      (a)          The Company has filed all reports,
            schedules, forms, statements and other documents required to be filed by it with the Commission under Sections 13, 14(a) and 15(d) of the Exchange Act, in the two years preceding the date hereof on a timely basis, except where the failure to
            file on a timely basis would not reasonably be expected to affect the Company’s ability to carry out and perform all of its obligations under this Agreement. As of their respective filing dates (or, if amended prior to the date of this
            Agreement, when amended), such documents filed with the Commission pursuant to the Exchange Act (the “SEC Documents”) complied in all material respects with the requirements of the
            Exchange Act and the rules and regulations of the Commission promulgated thereunder. The Company has made available to each Noteholder or its representatives, or each Noteholder has had access through the Commission’s EDGAR website to, true and
            complete copies of the SEC Documents.

       

      (b)          The Company is not and, after giving
            effect to the transactions contemplated by this Agreement, will not be required to register as an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
            thereunder.

       

      (c)           As of the date hereof, the Covered
            Documents (as defined below), taken as a whole, do not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
            made, not misleading. As used herein, “Covered Documents” means each of the following documents: (i) the Company’s Annual Report on Form 10-K for the fiscal year ended December 31,
            2021, including those portions of the Company’s Proxy Statement on Schedule 14A filed on March 25, 2022 that are incorporated therein by reference; (ii) the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022;
            and (iii) the Company’s Current Reports on Form 8-K (excluding any Current Reports or portions thereof that are furnished, and not filed, pursuant to Item 2.02 or Item 7.01 of Form 8-K, and any related exhibits) filed with the SEC after
            December 31, 2021.

       

      
        4

        
          

      

      2.5          Non-Contravention.  The execution, delivery and performance by the Company of this Agreement, the issuance of the Exchanged Shares and the consummation by the Company of the transactions contemplated by this Agreement
            will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination of any right or asset of the Company or any of its subsidiaries pursuant to, any
            indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property, right or
            assets of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii) result in the violation
            of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority applicable to the Company or any of its subsidiaries or by which the Company or any of its subsidiaries is bound
            or to which any of the property, right or assets of the Company or any of its subsidiaries is subject, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default or termination that, would not,
            individually or in the aggregate, have, or would reasonably be expected to have, a material adverse effect on the business, properties, management, financial position, stockholders’ equity, results of operations and prospects of the Company and
            its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement (a “Material Adverse Effect”).

       

      2.6          No Consents or Approvals.  No consent, filing, approval, authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution,
            delivery and performance by the Company of its obligations under this Agreement, the issuance of the Exchanged Shares and the consummation by the Company of the transactions contemplated by this Agreement, except for such filings, consents,
            approvals, authorizations, orders and registrations or qualifications (i) which have been obtained or made or (ii) as may be required by the Financial Industry Regulatory Authority, Inc. and the Nasdaq Market.

       

      2.7          No Registration Required.  Assuming the accuracy of each Noteholder’s representations in Section 3 hereof, it is not necessary in connection with the issuance of the Exchanged Shares to such Noteholder in the manner
            contemplated by this Agreement to register such issuances and sales under the Securities Act of 1933, as amended (the “Securities Act”). Upon issuance, the Exchanged Shares will be
            issued without any restricted CUSIP or other restrictive legend and will be freely tradable (other than by affiliates of the Company) under the Securities Act.

       

      SECTION 3.     Representations and Warranties of the Noteholders.  Each Noteholder, severally with respect to itself and its Represented Accounts (if any) and not jointly with other Noteholders, hereby
            represents and warrants to the Company that the following statements are true and correct as of the date of this Agreement and will be true and correct as of the Closing Date:

       

      3.1          Organization.  Such Noteholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization.

       

      
        5

        
          

      

      3.2          Authorization.

       

      (a)          Such Noteholder has full right, power
            and authority to exchange, sell, assign and transfer the Existing 2022 Notes and to execute and deliver this Agreement and to perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution
            and delivery by it of this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken.

       

      (b)          This Agreement has been duly authorized,
            executed and delivered by the Noteholder and constitutes a valid and binding obligation of the Noteholder, enforceable against the Noteholder in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
            insolvency, moratorium, reorganization or similar laws affecting creditors’ rights generally and by general equitable principles.

       

      3.3          Ownership.  Such Noteholder, or each of its Represented Accounts, is the beneficial owner of the Existing 2022 Notes set forth on the applicable Schedule A
            and, as of the Closing, will be the beneficial owner of such Existing 2022 Notes. Such Noteholder, or each of its Represented Accounts, has, and will have at the Closing, good, valid and marketable title to the Existing 2022 Notes set forth on
            the applicable Schedule A opposite the name of such Noteholder or Represented Account, free and clear of all mortgages, liens, pledges, charges, security interests, encumbrances,
            title retention agreements, options, preemptive rights, equity or other adverse claims thereto (collectively, “Liens”) (other than pledges or security interests that the Noteholder may
            have created in favor of a prime broker under and in accordance with its prime brokerage agreement with such broker, which will be terminated in connection with Closing). No proceeding relating to such Noteholder is pending or, to the knowledge
            of such Noteholder, is threatened before any court, arbitrator or administrative or governmental body that would adversely affect such Noteholder’s right to transfer the Existing 2022 Notes to the Company. Such Noteholder is not, and has not
            been during the consecutive three-month period preceding the date hereof, a director, officer or “affiliate” within the meaning of Rule 144 under the Securities Act of the Company. To its knowledge, such Noteholder did not acquire any of the
            Existing 2022 Notes, directly or indirectly, from the Company or any affiliate of the Company and no affiliate of the Company has held such Existing 2022 Notes within the past year.

       

      3.4          Transfer of the Existing 2022 Notes.  Such Noteholder has made an independent decision to transfer such Noteholder’s Existing 2022 Notes based on the information available to such Noteholder. Each Noteholder
            acknowledges that it has independently made its own analysis and decision to transfer such Noteholder’s Existing 2022 Notes and without reliance upon the Company or its affiliates or representatives and based on such information as it has
            deemed appropriate in its independent judgment. Such Noteholder has not relied on any information (in any form, whether written or oral, including any representation or warranty of the Company) furnished by or on behalf of the Company or any of
            its respective affiliates or representatives in making that decision (other than, with respect to the Company, filings made by the Company with the Commission and other public disclosures and the representations of the Company expressly set
            forth herein).

       

      
        6

        
          

      

      3.5          Investment.

       

      (a)         Such Noteholder is knowledgeable,
            sophisticated and experienced in business and financial matters and has previously invested in securities similar to the Exchanged Shares. Such Noteholder is able to bear the economic risk of its investment in the Exchanged Shares and is
            presently able to afford the complete loss of such investment and has been afforded access to information about the Company and its affiliates and their financial condition, results of operations, business, property and management sufficient to
            enable such Noteholder to evaluate its investment in the Exchanged Shares. Such Noteholder was given a meaningful opportunity to negotiate the terms of the transactions contemplated hereby and neither the Company nor any of its affiliates or
            representatives put any pressure on such Noteholder to respond to the opportunity to participate in the transactions contemplated hereby or condition its participation on such Noteholder exchanging a minimum amount of its Existing 2022 Notes.
            Such Noteholder and Represented Account for which it is acting are each an “accredited investor” as defined in Rule 501(a) under the Securities Act and such Noteholder and any Represented Account for which it is acting are each a “qualified
            institutional buyer” as defined in Rule 144A under the Securities Act.

       

      (b)         Such Noteholder (i) has received such
            information about the Company as requested by such Noteholder, including the SEC Documents and the Covered Documents; (ii) understands and accepts that the Exchanged Shares to be issued pursuant to this Agreement involve risk, including those
            described or incorporated by reference in the SEC Documents and the Covered Documents, as applicable, and (iii) has made an independent decision to acquire the Exchanged Shares based on the information available to such Noteholder. Such
            Noteholder acknowledges that it has independently made its own analysis and decision to acquire the Exchanged Shares without reliance upon the Company or its respective representatives and based on such information as it has deemed appropriate
            in its independent judgment. Such Noteholder has not relied on any information (in any form, whether written or oral, including any representation or warranty of the Company) furnished by or on behalf of the Company or its respective affiliates
            and representatives in making that decision (other than, with respect to the Company, filings made by the Company with the Commission and other public disclosures and the representations of the Company expressly set forth herein). Such
            Noteholder further acknowledges that (i) it has consulted its own tax advisors and (ii) it has not relied on the Company or its respective affiliates or representatives for any tax advice related to the transactions contemplated hereunder.

       

      (c)         Such Noteholder acknowledges and
            understands that (i) the Company possesses material nonpublic information regarding the Company not known to the Noteholder that may impact the value of the Common Stock of the Company (the “Information”),
            and that the Company is not disclosing the Information to such Noteholder. Such Noteholder understands, based on its experience, the disadvantage to which such Noteholder is subject due to the disparity of information between the Company and
            such Noteholder. Notwithstanding such disparity, such Noteholder has deemed it appropriate to enter into this Agreement and to the exchange of the Existing 2022 Notes for the Exchanged Shares and the consummation by the Noteholder of the
            transactions contemplated by this Agreement.

       

      
        7

        
          

      

      (d)          Such Noteholder agrees that none of the
            Company, its affiliates, principals, employees and agents shall have any liability to such Noteholder whatsoever due to or in connection with the Company’s use or non-disclosure of the Information or otherwise as a result of the exchange of the
            Existing 2022 Notes for the Exchanged Shares and the consummation of the transactions contemplated by this Agreement, and such Noteholder hereby irrevocably waives any claim that it might have based on the failure of the Company to disclose the
            Information.

       

      (e)          Such Noteholder is acquiring the
            Exchanged Shares to be issued to it pursuant to this Agreement for investment purposes and solely for its account without a view to the distribution thereof.

       

      (f)          None of the Company nor any of its
            respective affiliates, representatives, officers, employees, agents or controlling persons have provided any investment advice or rendered any opinion to such Noteholder as to whether the transaction contemplated hereby is prudent or suitable.

       

      3.6          Compliance with Laws.

       

      (a)        Each Noteholder will comply with all
            applicable laws and regulations in effect in any jurisdiction in which the Noteholder exchanges the Existing 2022 Notes or is issued the Exchanged Shares and will obtain any consent, approval or permission required for such acquisitions or
            exchange under the laws and regulations of any jurisdiction to which the Noteholder is subject or in which the Noteholder makes such acquisitions or exchanges, and the Company shall have no responsibility therefor.

       

      (b)         Each Noteholder is a resident of the
            jurisdiction set forth on the applicable Schedule A hereto.

       

      3.7          No Guarantees.  Each Noteholder confirms that none of the Company nor any of its respective affiliates or representatives has (A) given any guarantee or representation as to the potential success, return, effect or
            benefit (either legal, regulatory, tax, financial accounting or otherwise) of the exchange of the Existing 2022 Notes for the Exchanged Shares, or (B) made any representation to such Noteholder regarding the legality of the transactions
            contemplated hereby under applicable investment guidelines, laws or regulations (other than, with respect to the Company, the representations of the Company expressly set forth herein).

       

      3.8          Non-Contravention.  The execution, delivery and performance by the Noteholder of this Agreement, the exchange of the Existing 2022 Notes for the Exchanged Shares and the consummation by the Noteholder of the
            transactions contemplated by this Agreement will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination of any right or asset of the Noteholder or
            any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Noteholder or any of its subsidiaries is a party or by which the Noteholder or any of its subsidiaries is
            bound or to which any of the property, right or assets of the Noteholder or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Noteholder or
            any of its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority applicable to the Noteholder or any of its subsidiaries
            or by which the Noteholder or any of its subsidiaries is bound or to which any of the property, right or assets of the Noteholder or any of its subsidiaries is subject, except, in the case of clauses (i) and (iii) above, for any such conflict,
            breach, violation, default or termination that, would not, individually or in the aggregate, have, or would reasonably be expected to have a material adverse effect on the ability of such Noteholder to carry out its obligations hereunder.

       

      
        8

        
          

      

      3.9         No Brokers or Finders.  None of such Noteholder nor any of its officers or directors or persons serving in a similar capacity has retained or authorized any agent, investment banker, financial advisor, broker, finder or
            other intermediary to act on behalf of such Noteholder or incurred any liability for any agent’s, banker’s, financial advisor’s, broker’s or finder’s fees or commissions in connection with the transactions contemplated by this Agreement.

       

      3.10       Represented Accounts.  If a Noteholder is acting on behalf of a Represented Account hereunder, such Noteholder has (i) sole investment discretion with respect to each such Represented Account, (ii) full power to make
            the foregoing representations, warranties and covenants on behalf of such Represented Account and (iii) the contractual authority to enter into this Agreement and to carry out the transactions contemplated hereby with respect to such
            Represented Account.

       

      3.11       No Manipulation of Stock.  Such Noteholder has not taken, in violation of applicable law, any action designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of
            the Common Stock to facilitate the transactions contemplated hereby or the sale or resale of the shares of Common Stock.

       

      3.12       Nature of Transactions.  Such Noteholder had a sufficient amount of time to consider whether to participate in the transactions contemplated by this Agreement, and none of the Company or its respective affiliates and
            representatives has placed any pressure on such Noteholder to respond to the opportunity to participate in such transactions. The Noteholder acknowledges that the terms of such transactions have been mutually negotiated between such Noteholder
            and the Company.

       

      3.13       No HSR.  The transactions contemplated hereby do not require any filing by such Noteholder (or its affiliates) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).

       

      SECTION 4.       Termination.

       

      4.1         Conditions of Termination.  Notwithstanding anything to the contrary contained herein, with respect to any individual Noteholder, this Agreement may be terminated (a) at any time by mutual written agreement of the
            Company and the respective Noteholder, (b) by either Party if (i) the Closing shall not have occurred on or before August 17, 2022 or (ii) any governmental authority of competent jurisdiction shall have issued or entered any governmental order
            or taken any other action permanently restraining, enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated herein; provided, however, the right to terminate this Agreement pursuant to
            Section 4.1(b) shall not be available to any Party whose failure to comply with or perform in any material respect any covenant under this Agreement shall have caused the Closing not to occur on or before such termination date.

       

      
        9

        
          

      

      4.2         Effect of Termination.  In the event of termination pursuant to Section 4.1 hereof, this Agreement shall become null and void with respect to any individual Noteholder and have no effect (other than this Section 4.2 and
            Section 6, which shall survive termination) with no liability on the part of the Company or such Noteholder, or their respective directors, officers, agents or stockholders, with respect to this Agreement, except for the liability of any fraud,
            or willful or intentional breach of this Agreement.

       

      SECTION 5.        Defined Terms.  Capitalized terms used, but not otherwise defined, in this Agreement have the meanings set forth in this Section 5.

       

      5.1          “Bond Reference Price” means $1,348.57

       

      5.2          “Daily Exchange Price” means the sum of (i) the product of (A) the difference between (a) the applicable Daily VWAP during the VWAP Period and (b) Share Reference Price, multiplied by (B) the Existing Conversion
            Ratio, multiplied by (C) the Hedge Ratio, plus (ii) the Bond Reference Price.

       

      5.3          “Daily Exchange Ratio” means the quotient resulting from (i) the applicable Daily Exchange Price for the applicable trading day during the VWAP Period, divided by (ii) the Daily VWAP for such trading day during the
            VWAP Period.

       

      5.4         “Daily VWAP” means, with respect to any Trading Day (as defined in the Indenture) during the VWAP Period, the per share volume-weighted average price of the Common Stock on the Nasdaq Market (during standard market hours
            from 9:30am to 4:00pm) as displayed under the heading “Bloomberg VWAP” on Bloomberg page “GPRE <equity> AQR” (or its equivalent successor if such page is not available) with respect to such Trading Day (or if such volume-weighted average
            price is unavailable, the market value of one share of Common Stock on such Trading Day determined, using a volume weighted average method, by a nationally recognized independent investment banking firm retained for this purpose by the
            Company). The “Daily VWAP” shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours.

       

      5.5           “Exchange Ratio” means the sum of each Daily Exchange Ratio during the VWAP Period.

       

      5.6         “Exchanged Shares” means the product of (i) the principal amount of the Existing 2022 Notes set forth on the applicable Schedule A for each Noteholder divided
            by 1,000, and (ii) the Exchange Ratio.

       

      5.7          “Existing Conversion Ratio” means 35.7143.

       

      5.8          “Hedge Ratio” means 80%.

       

      5.9          “Share Reference Price” means $37.48.

       

      5.10        “VWAP Period” means Trading Day (as defined in the Indenture) immediately following the date of this Agreement.

       

          

      
        10

        
          

      

      SECTION 6.        Miscellaneous.

       

      6.1         Further Assurances.  In case at any time after the Closing any further action is necessary or desirable to carry out the purposes of this Agreement or the transactions contemplated hereby, each of the Parties will take
            such further action (including the execution and delivery of such further instruments and documents) as the other Party may reasonably request, at the requesting Party’s expense.

       

      6.2          Assignability.  Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by either the Company or a Noteholder without the prior written consent of
            the other party.

       

      6.3          Counterparts.  This Agreement may be executed simultaneously in counterparts (including by means of facsimile or other electronic transmission), any one of which need not contain the signatures of more than one Party,
            but all such counterparts taken together shall constitute one and the same agreement.

       

      6.4        Descriptive Headings; Interpretation.  The headings and captions used in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Any capitalized
            terms used in Schedule A and not otherwise defined therein shall have the meanings set forth in this Agreement. The use of the word “including” herein shall mean “including without
            limitation”. The Parties intend that each representation, warranty and covenant contained herein shall have independent significance.

       

      6.5         Entire Agreement.  This Agreement and the agreements and documents referred to herein contain the entire agreement and understanding among the Parties with respect to the subject matter hereof and supersede all prior
            agreements and understandings, whether written or oral, relating to such subject matter in any way.

       

      6.6         Amendment.  This Agreement may be amended, modified, discharged, terminated or supplemented but only in writing (including a writing evidenced by a facsimile transmission or other electronic transmission) signed by the
            Party against which enforcement is sought.

       

      6.7          Expenses.  Except as set forth in the following sentence, each Party will bear its own fees and expenses in connection with the transactions contemplated hereby.

       

      6.8         APPLICABLE LAW; WAIVER OF JURY TRIAL.  THIS AGREEMENT, AND ANY CLAIM, COUNTERCLAIM OR DISPUTE OF ANY KIND OR NATURE WHATSOEVER ARISING OUT OF OR IN ANY WAY RELATING TO THIS AGREEMENT, SHALL BE GOVERNED BY AND CONSTRUED
            AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. THE PARTIES AGREE TO WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY DISPUTE ARISING FROM OR RELATED TO THIS AGREEMENT.

       

      6.9         Submission to Jurisdiction.  Each Party agrees that any suit, action or proceeding bought by it against the other Party arising out of or based upon this Agreement or the transactions contemplated hereby shall be
            instituted exclusively in federal or state courts located in the State of New York, and waives any objection which it may now or hereafter have to the laying of venue of any such proceeding.

       

      
        11

        
          

      

      6.10        Survival. All authority herein conferred or agreed to be conferred in this Agreement shall survive the dissolution of such Noteholder and any representation, warranty, undertaking and obligation of such Noteholder
            hereunder shall be binding upon the trustees in bankruptcy, legal representatives, successors and assigns of such Noteholder.

       

      6.11      Taxation. The Noteholder acknowledges that, if a Noteholder is a United States person for U.S. federal income tax purposes, either (i) the Company must be provided with a correct taxpayer identification number (“TIN”) (generally a person’s social security or federal employer identification number) and certain other information on a properly completed and executed Internal Revenue Service (“IRS”) Form W-9, which is provided herein on Exhibit C attached to this Agreement, or (ii) another basis for exemption from
            backup withholding must be established. The Noteholder further acknowledges that, if a Noteholder is not a United States person for U.S. federal income tax purposes, the Company must be provided the appropriate properly completed and executed
            IRS Form W-8, attesting to that non-U.S. Noteholder’s foreign status. The Company shall request all necessary tax forms, including IRS Form W-9 and IRS Form W-8, as applicable, from each Noteholder as may be reasonably necessary to reduce or
            eliminate any such withholding or deduction. Each Noteholder further acknowledges that, if it fails to provide such necessary tax forms, payments made to such Noteholder pursuant to this Agreement may be subject to 30% U.S. federal withholding
            on amounts, if any, attributable to accrued and unpaid interest or 24% U.S. federal backup withholding unless such Noteholder properly establishes an exemption from, or a reduced rate of, such withholding or backup withholding.

       

      6.12       Notices. All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be delivered by electronic mail to the address
            designated below, and shall be effective on the date that the email is sent (provided that the sender has not received any “bounceback”). However, if the time of deemed receipt of any notice is not before 5:30 p.m. New York City time on a
            business day at the address of the recipient it is deemed to have been received at the commencement of business on the next business day:

       

      If to the Company:

       

      1811 Aksarben Drive

      Omaha, NE 68106

      Telephone: (402) 952-4906

      E-mail: Patrich.Simpkins@gpreinc.com

      Attention: Chief Financial Officer

       

      If to the Noteholders:

       

      To the address or addresses set forth on Schedule A

       

      6.13       Notification of Changes.  Each Noteholder hereby covenants and agrees to notify the Company upon the occurrence of any event prior to the Closing Date which would cause any representation, warranty or covenant of such
            Noteholder contained in this Agreement to be false or incorrect.

       

      
        12

        
          

      

      6.14        No Construction Against Draftsperson.  The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement
            shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.

       

      6.15      No Integration.  The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the
            offer or sale of the Exchanged Shares in a manner that would (i) require the registration under the Securities Act of the offer and sale of any of the Exchanged Shares in the manner contemplated by this Agreement or (ii) be aggregated with the
            sale of the Exchanged Shares for purposes of the rules and regulations of any trading market on which the Common Stock is listed such that it would require shareholder approval for the sale or issuance of the Exchanged Shares as contemplated by
            this Agreement.

       

      (Signatures on next page)

       

      
        13

        
          

      

      IN WITNESS WHEREOF, the Parties hereto have executed this Exchange Agreement as of the date first written above.

       

      	 	
              COMPANY:

            	 
	 	 	 	 
	 	
              GREEN PLAINS INC.

            	 
	 	 	 
	 	
              By:

            	
              /s/ G. Patrich Simpkins

            	 
	 	 	 	 
	 	
              Name:

            	
              G. Patrich Simpkins

            	 
	 	 	 	 
	 	
              Title:

            	
              Chief Financial Officer

            	 

       

        

      	 	
              NOTEHOLDER:

            	 
	 	 	 
	 	
              For:  CSS LLC

            	 
	 	 	 	 
	 	
              By:

            	
              /s/ Mitchell R. Bialek

            	 
	 	 	 	 
	 	
              Name:

            	
              Mitchell R. Bialek

            	 
	 	 	 	 
	 	
              Title:

            	
              CCO

            	 

       

      

      
        [Signature Page to Exchange Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]